Early research (Phase 1)Study completedNCT00000976
What this trial is testing
A Phase I Study of the Safety and Pharmacokinetics of Recombinant Human CD4-Immunoglobulin G (rCD4-IgG) Administered by Intravenous Bolus Injection in Combination With Oral Zidovudine in Patients With AIDS and AIDS-Related Complex
Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 40